Maša Alečković

MedicineChemistryImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “SQ3370, the first clinical click chemistry-activated cancer therapeutic, shows safety in humans and translatability across species”.

SQ3370, the first clinical click chemistry-activated cancer therapeutic, shows safety in humans and translatability across species

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.03.28.534654

N/A

1.1DataRank · unranked

26 citations

Nathan A. Yee, Michael Zakharian, Maša Alečković, Amir Mahmoodi, Tri‐Hung Nguyen +2 more

Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers

Cell(2020)10.1016/j.cell.2020.07.009

N/A

1.1DataRank · unranked

1266 citations

Han Sang Kim, Linda Bojmar, Kofi Ennu Gyan, Michele Cioffi, Jonathan M. Hernandez +95 more

Heterogeneity and transcriptional drivers of triple-negative breast cancer

Cell Reports(2023)10.1016/j.celrep.2023.113564

N/A

0.510DataRank · unranked

29 citations

Daniel Temko, Laura E. Stevens, Marco Seehawer, Anne Fassl, Katherine C. Murphy +33 more

Development of a First-in-Class Click Chemistry–Based Cancer Therapeutic, from Preclinical Evaluation to a First-in-Human Dose Escalation Clinical Trial

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-24-2539

N/A

0.284DataRank · unranked

5 citations

Nathan K. Yee, Maša Alečković, Michael Zakharian, Amir Mahmoodi, Stefanie Wagner +5 more

Interim phase 1 results for SQ3370 in advanced solid tumors.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.3085

N/A

0.241DataRank · unranked

4 citations

Kathleen Batty, Maša Alečković, Vivek A. Bhadri, Nam Q. Bui, Alexander Guminski +10 more

953 Treatment with SQ3370, a doxorubicin-based therapeutic, corresponds with immunomodulation of the tumor microenvironment

Regular and Young Investigator Award Abstracts(2022)10.1136/jitc-2022-sitc2022.0953

N/A

0DataRank · unranked

0 citations

Sangeetha Srinivasan, Jesse M. McFarland, Leslie Priddy, Matthew Tso, Jose Mejia Oneto +1 more

The impact of tumor epithelial and microenvironmental heterogeneity on treatment responses in HER2+ breast cancer

JCI Insight(2021)10.1172/jci.insight.147617

N/A

0DataRank · unranked

42 citations

Shayna Stein, Otto Metzger, Jennifer Eng, Natalie L. Kingston, Nicholas W. Harper +18 more